The Effect of Platelet Rich Plasma on Non-scarring Alopecia

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the clinical efficacy of platelet rich plasma (PRP) injections for non-scaring alopecia in women. A randomized, placebo-controlled clinical trial will be performed where patients with non-scarring alopecia will either receive injections of their own PRP or injections of normal saline (placebo). Patients in the treatment group (Group A) will have a small amount of their own blood drawn and have their PRP injected into their scalp four times. The injections will be given at weeks zero, four, eight, and twenty four. The placebo group (Group B) will be given the same schedule but will receive sham injections only and will not have any blood drawn. Both groups will have clinical data collected at all visits, including a screening visit before enrollment and a final assessment visit at week 40, for a total of 6 study visits per patient. Data collection will include representative photographs of the scalp and measurements of hair thickness. The results from the two groups will then be compared. In summary, all study participants will have a screening visit before enrollment, four study visits for sub-dermal scalp injections, and one final assessment visit at week 40.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03689452
Study type	Interventional
Source	Icahn School of Medicine at Mount Sinai
Contact
Status	Completed
Phase	N/A
Start date	October 1, 2018
Completion date	June 3, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02591355` - Evaluate the Clinical Effectiveness of RegenKit Platelet-rich Plasma (PRP) in Androgenetic Alopecia Treatment	N/A
Withdrawn	`NCT03852992` - Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia	Phase 2
Recruiting	`NCT06239207` - Efficacy and Safety of Exosomes Versus Platelet Rich Plasma in Patients of Androgenetic Alopecia	Phase 2
Completed	`NCT04945226` - A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001	Phase 1/Phase 2
Completed	`NCT01437163` - Treatment of Androgenetic Alopecia in Males and Females	N/A
Completed	`NCT01548066` - The Efficacy and Safety of Topical Valproic Acid in Preventing Hair Loss	Phase 2
Completed	`NCT01226459` - Clinical Trial in Females for Female Pattern Hair Loss	Phase 3
Recruiting	`NCT06118866` - A Study to Assess the Efficacy and Safety of HMI-115 in Male Subjects With Androgenetic Alopecia	Phase 2
Completed	`NCT06149221` - Penetration-enhanced Direct DBD Non-thermal Plasma for Hair Loss	N/A
Withdrawn	`NCT04882969` - Thulium Laser and KeraFactor for the Treatment of Androgenetic Alopecia	N/A
Completed	`NCT01231607` - Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia	Phase 3
Completed	`NCT04446429` - Anti-Androgen Treatment for COVID-19	N/A
Completed	`NCT02729415` - Point-of-Care Adipose-derived Cells for Hair Growth	N/A
Completed	`NCT02279823` - A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia	Phase 2
Not yet recruiting	`NCT01227031` - Pharmacogenomic Study of Androgenetic Alopecia	N/A
Completed	`NCT00981461` - Treatment of Androgenetic Alopecia in Females, 9 Beam	N/A
Completed	`NCT01451021` - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss	Phase 2
Completed	`NCT00151515` - A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss	Phase 3
Completed	`NCT03694067` - Androgenetic Alopecia and the JAK-STAT Pathway
Completed	`NCT03753113` - Evaluating the Topical Herbal Solution on the Treatment of Male Pattern Hair Loss and Comparison With Minoxidil 5%	Phase 3